LESCH – NYHAN SYNDROME (LNS) - THE REVIEW
Lesch-Nyhan syndrome (LNS) is a rare X-linked disorder caused by mutations in the HPRT1 gene, which encodes an important enzyme in the purine salvage pathway. Symptoms of LNS include dystonia, gout, intellectual disability, and self-harm. Although the disease was described in 1964, it remains unclear how abnormalities in hypoxanthine and guanine recycling can lead to such significant neurological deficits. Several studies have proposed different hypotheses regarding the etiology of the disease and various treatment options have been proposed, but none have led to a satisfactory explanation of the pathophysiology of the disease. New technologies such as sequencing, optogenetics, genome editing, and induced pluripotent stem cells may provide a unique opportunity to map the precise sequential pathways from genotype to disease phenotype.
Authors
- Daria Madycka (ORCID: https://orcid.org/0000-0001-8682-1229)
- Małgorzata Słaboń (ORCID: https://orcid.org/0000-0003-1627-8878)
- Karol Stępniak (ORCID: https://orcid.org/0000-0002-8134-7967)
- Joanna Wrona
- Kinga Wnuczek
- Wiktor Telega
- Aleksandra Kaźmierczyk (ORCID: https://orcid.org/0009-0007-7283-2518)
- Jędrzej Kęsik (ORCID: https://orcid.org/0000-0001-8317-0213)
- Weronika Skrzypek (ORCID: https://orcid.org/0009-0004-3353-1390)
Institutions
- 1 Military Clinical Hospital with Outpatient Clinic (PL)
Publication Details
- Journal
- International Journal of Innovative Technologies in Social Science
- Published
- 2025-09-30
- DOI
- https://doi.org/10.31435/ijitss.3(47).2025.3862
- Primary Topic
- Biochemical and Molecular Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00